Skip to content

A Comparison of McGrath MAC®, Pentax-AWS® and Macintosh Direct Laryngoscopes for Nasotracheal Intubation

A Comparison of McGrath MAC®, Pentax-AWS® and Macintosh Direct Laryngoscopes for Nasotracheal Intubation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03337555
Enrollment
123
Registered
2017-11-09
Start date
2017-11-07
Completion date
2018-02-20
Last updated
2019-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation;Difficult

Brief summary

A comparison of intubation time, difficulty of intubation in nasotracheal intubation using McGrath MAC®, Pentax-AWS® and Macintosh direct laryngoscopes

Detailed description

This trial is prospective randomized trial. The Objects are adult patients who need nasotracheal intubation for surgery. Using computed randomized table, participants are assigned to three groups, McGrath MAC®, Pentax-AWS® and Macintosh direct laryngoscopes. The intubation will be done by One expert anesthesiologist who have more than 10 years experience. Investigators compare intubation time, success rate and difficulty between three groups.

Interventions

DEVICEMcGrath

McGrath videolaryngoscope

DEVICEPentax

Pentax videolaryngoscope

DEVICEMacintosh

Macintosh direct laryngoscope

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 19 years old * ASA I or II * Patients who need nasotracheal intubation for surgery

Exclusion criteria

* Anatomical deformity in head and neck * Modified Mallampati score IV * Bleeding tendency in preoperative evaluation

Design outcomes

Primary

MeasureTime frameDescription
Intubation timewithin 5 minutesfrom endotracheal tube pass the nostril to end-tidal CO2 appear

Secondary

MeasureTime frameDescription
Success ratewithin 5 minutesFailure defined intubation time more than 120sec or SaO2 less than 95%

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026